Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,820.31 -1.34 -0.05%
FTSE 100 6,813.60 +9.73 0.14%
DAX 8,472.36 +0.16 0.00%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

Edwards Lifesciences Corp

+ Add to Watchlist

EW:US

66.0000 USD 0.3700 0.56%

As of 20:04:05 ET on 05/21/2013.

Company Profile for Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.

Contact Information

Edwards Lifesciences Corp

One Edwards Way
Irvine, CA 92614
United States
Phone: 1-949-250-2500

Key Executives for Edwards Lifesciences Corp (EW)

Michael A MussallemChairman/CEOThomas M Abate "Tom"VP/CFO
Aimee S WeisnerVP/General CounselCarlyn D SolomonVP:Critical Care & Vascular
Paul C RedmondVP:Global Corporate OperationsDonald E Bobo JrVP:Heart Valve Therapy
Christine Z McCauleyVP:Human ResourcesHuimin WangVP:Japan & Asia Pacific
Bruce P GarrenVP:Public AffairsJohn H Kehl JrVP:Strategy & Corporate Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil